XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Proceeds from subsidiary equity issuance $ 6 $ 0
Cash flows from operating activities:    
Net income (loss) 423 (160)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Net gain from securities transactions (285) (486)
Purchases of securities (886) (292)
Proceeds from sales of securities 3,130 488
Purchases to cover securities sold, not yet purchased (690) 0
Proceeds from securities sold, not yet purchased 0 1,129
Changes in receivables and payables relating to securities transactions (1,824) (1,798)
Depreciation and amortization 252 248
Impairment 0 8
Equity earnings from non-consolidated affiliates (22) (18)
Deferred taxes 36 1
Other, net 43 48
Changes in other operating assets and liabilities (772) 421
Net cash used in operating activities (595) (411)
Cash flows from investing activities:    
Capital expenditures (220) (231)
Acquisition of businesses, net of cash acquired (1) (43)
Purchase of additional interests in consolidated subsidiaries 0 (252)
Proceeds from disposition of assets 17 54
Other, net 2 (1)
Net cash used in investing activities (202) (473)
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 280 600
Partnership contributions 0 612
Dividends and distributions to non-controlling interests in subsidiaries (31) (10)
Proceeds from Holding Company senior unsecured notes 0 1,195
Repayments of Holding Company senior unsecured notes 0 (1,175)
Proceeds from subsidiary borrowings 424 1,150
Repayments of subsidiary borrowings (450) (1,120)
Other, net (4) (9)
Net cash provided by financing activities 225 1,243
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (3) 9
Add back decrease in cash of assets held for sale 0 20
Net (decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents (575) 388
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 2,468 2,637
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period 1,893 3,025
Icahn Enterprises Holdings    
Proceeds from subsidiary equity issuance 6 0
Cash flows from operating activities:    
Net income (loss) 423 (160)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Net gain from securities transactions (285) (486)
Purchases of securities (886) (292)
Proceeds from sales of securities 3,130 488
Purchases to cover securities sold, not yet purchased (690) 0
Proceeds from securities sold, not yet purchased 0 1,129
Changes in receivables and payables relating to securities transactions (1,824) (1,798)
Depreciation and amortization 252 248
Impairment 0 8
Equity earnings from non-consolidated affiliates (22) (18)
Deferred taxes 36 1
Other, net 43 48
Changes in other operating assets and liabilities (772) 421
Net cash used in operating activities (595) (411)
Cash flows from investing activities:    
Capital expenditures (220) (231)
Acquisition of businesses, net of cash acquired (1) (43)
Purchase of additional interests in consolidated subsidiaries 0 (252)
Proceeds from disposition of assets 17 54
Other, net 2 (1)
Net cash used in investing activities (202) (473)
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 280 600
Partnership contributions 0 612
Dividends and distributions to non-controlling interests in subsidiaries (31) (10)
Proceeds from Holding Company senior unsecured notes 0 1,195
Repayments of Holding Company senior unsecured notes 0 (1,175)
Proceeds from subsidiary borrowings 424 1,150
Repayments of subsidiary borrowings (450) (1,120)
Other, net (4) (9)
Net cash provided by financing activities 225 1,243
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (3) 9
Add back decrease in cash of assets held for sale 0 20
Net (decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents (575) 388
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 2,468 2,637
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 1,893 $ 3,025